Our R&D Focus

Our R&D focus is on developing cell therapies for diabetes, cancer, neuronal diseases, and blood diseases.

Collaborations with biopharma and other research and development organizations form a core component of our strategy to accelerate the development of cell therapies. We pursue strategic partnerships for cell validation, pre-clinical testing, and therapy development. We view ourselves as the front-end provider of the cellular material and enabler of successful clinical programs.